Copyright
©20???? Baishideng Publishing Group Co.
World J Hepatol. Jun 27, 2011; 3(6): 157-163
Published online Jun 27, 2011. doi: 10.4254/wjh.v3.i6.157
Published online Jun 27, 2011. doi: 10.4254/wjh.v3.i6.157
Table 3 T-scores and prevalence of abnormal BMD between disease groups
| Viral n = 46 | Alcohol n = 20 | Cholestasis n = 25 | Other n = 26 | P value | |
| T-score lumbar spine mean (SD) | -1.08 (1.35) | -1.51 (1.35) | -1.43 (1.23) | -1.30 (1.43) | 0.552 |
| T-score femoral neck mean (SD) | -1.11 (1.07) | -1.31 (1.02) | -1.30 (0.81) | -1.03 (1.05) | 0.706 |
| Low BMD at 1 or both sites number (%) | 31 (67.4%) | 13 (65.0%) | 18 (72.0%) | 18 (69.2%) | 0.963 |
| Low BMD lumbar spine number (%) | 22 (47.8%) | 11 (55.0%) | 15 (60.0%) | 18 (69.2%) | 0.556 |
| Low BMD femoral neck number (%) | 26 (56.5%) | 12 (60.0%) | 15 (60.0%) | 14 (53.8%) | 0.993 |
- Citation: Mitchell R, McDermid J, Ma MM, Chik CL. MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol 2011; 3(6): 157-163
- URL: https://www.wjgnet.com/1948-5182/full/v3/i6/157.htm
- DOI: https://dx.doi.org/10.4254/wjh.v3.i6.157